As the pro-inflammatory effect of the NLRP3 inflammasome is deleterious, the discovery of effective and specific drugs that alter NLRP3 inflammasome function has the potential to improve the symptoms of sepsis and AKI. The gene discussed is NLRP3; the disease is Sepsis.